top of page
AdobeStock_352149697.jpeg

Safety and efficacy of myofascial release therapy in the treatment of patients with hemophilic ankle arthropathy. Single-blind randomized clinical trial

Cite

Full Text Link

Randomized Controlled Trial

-

Fascial

Physiother Theory Pract. 2024 Mar 26:1-10. doi: 10.1080/09593985.2024.2334752. Online ahead of print.

Authors:

Elena Donoso-Úbeda, Roberto Ucero-Lozano, Javier Meroño-Gallut, Rubén Cuesta-Barriuso, Raúl Pérez-Llanes

Abstract.

Background: Hemophilia is characterized by degenerative joint damage. Patients with hemophilic arthropathy present joint damage, reduced range of motion, and decreased strength and functional capacity. Myofascial release therapy aims to decrease pain and improve tissue mobility and functionality. Objectives: To evaluate the safety and efficacy of myofascial release therapy in patients with hemophilic ankle arthropathy. Method: Single-blind randomized controlled trial. Fifty-eight adult patients with hemophilia were randomly allocated to the experimental group (myofascial release therapy with foam roller) or the control group (no intervention whatsoever). The daily home protocol of myofascial release therapy for the lower limbs using a foam roller lasted eight consecutive weeks. The primary variable was the safety of myofascial release therapy (weekly telephone follow-up). The secondary variables were pain intensity (visual analog scale), range of motion (goniometer), functional capacity (2-Minute Walk Test) and muscle strength (dynamometer), at baseline and at 8 and 10 weeks. Results: During the experimental phase, none of the patients in the experimental group developed ankle hemarthrosis. There were statistically significant changes in time*group interaction in ankle dorsal flexion (F[1.75] = 10.72; p < .001), functional capacity (F[1.16] = 5.24; p = .009) and gastrocnemius strength (F[2] = 26.01; p < .001). The effect size of the changes after the intervention was medium-large in pain intensity (d = -1.77), functional capacity (d = 1.34) and gastrocnemius strength (d = 0.76). Conclusion: Myofascial release therapy is a safe form of physical therapy for patients with hemophilia. Myofascial release therapy can effectively complement prophylactic pharmacological treatment in patients with hemophilic arthropathy, improving range of motion in dorsal flexion, functional capacity and gastrocnemius strength. Keywords: Hemophilia; ankle; myofascial release therapy; physical therapy modalities; randomized clinical trials.

Publication Date: 

2024 Mar

OEID: 

7193

Donoso-úbeda, E., Ucero-lozano, R., Meroño-gallut, J., Cuesta-barriuso, R., Pérez-llanes, R. (2024) 'Safety and efficacy of myofascial release therapy in the treatment of patients with hemophilic ankle arthropathy. Single-blind randomized clinical trial', Physiother Theory Pract. 2024 Mar 26:1-10. doi: 10.1080/09593985.2024.2334752. Online ahead of print.

Sponsored by 

logo-footer-k.png

Search    Explore    About    Join    Web Policy     Contact Us

Copyright © 2023 OsteoEvidence. All Rights Reserved.
 

bottom of page